These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36137914)

  • 41. Evolving role of neoadjuvant therapy in rectal cancer.
    Schrag D
    Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation.
    Caricato M; Borzomati D; Ausania F; Tonini G; Rabitti C; Valeri S; Trodella L; Ripetti V; Coppola R
    Surg Endosc; 2006 Aug; 20(8):1203-7. PubMed ID: 16703429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

  • 45. Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational study.
    Peltrini R; Castiglioni S; Imperatore N; Ortenzi M; Rega D; Romeo V; Caracino V; Liberatore E; Basti M; Santoro E; Bracale U; Delrio P; Mucilli F; Guerrieri M; Corcione F
    Tech Coloproctol; 2023 Jan; 27(1):53-61. PubMed ID: 36239872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing patterns of neoadjuvant therapy for locally advanced rectal cancer: A narrative review.
    He W; Li Q; Li X
    Crit Rev Oncol Hematol; 2023 Jan; 181():103885. PubMed ID: 36464124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial.
    Pucciarelli S; De Paoli A; Guerrieri M; La Torre G; Maretto I; De Marchi F; Mantello G; Gambacorta MA; Canzonieri V; Nitti D; Valentini V; Coco C
    Dis Colon Rectum; 2013 Dec; 56(12):1349-56. PubMed ID: 24201388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
    BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organ preservation in rectal cancer: have all questions been answered?
    Marijnen CA
    Lancet Oncol; 2015 Jan; 16(1):e13-22. PubMed ID: 25638548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
    Wasmuth HH; Rekstad LC; Tranø G
    Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy.
    van Lingen CP; Zeebregts CJ; Gerritsen JJ; Mulder HJ; Mastboom WJ; Klaase JM
    Int J Gastrointest Cancer; 2003; 34(2-3):129-34. PubMed ID: 15361646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local excision for early rectal cancer in the era of neoadjuvant strategies.
    Tepetes K; Spyridakis ME
    Hepatogastroenterology; 2007 Sep; 54(78):1689-93. PubMed ID: 18019696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal management of small rectal cancers: TAE, TEM, or TME?
    Garcia-Aguilar J; Holt A
    Surg Oncol Clin N Am; 2010 Oct; 19(4):743-60. PubMed ID: 20883951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local excision followed by early radical surgery in rectal cancer: long-term outcome.
    Junginger T; Goenner U; Hitzler M; Trinh TT; Heintz A; Wollschläger D
    World J Surg Oncol; 2019 Oct; 17(1):168. PubMed ID: 31594546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal.
    Mortenson MM; Khatri VP; Bennett JJ; Petrelli NJ
    Surg Oncol Clin N Am; 2007 Jan; 16(1):177-97. PubMed ID: 17336243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.